Mobiliar took part in a $35m round for medicine transportation system developer SkyCell while Nice Investment co-led wealth management software provider Fount's $33.4m series C.
Funding
SkyCell, a Switzerland-based developer of cold-chain pharmaceutical transport systems, received $35m in series C funding yesterday from investors including insurance firm Mobiliar. Investment holding company ADQ’s DisruptAD also took part in the round, as did Shuaa Capital and unnamed family offices, while a Swiss cantonal bank supplied a debt facility of undisclosed size. MVM Partners led a $62m round for SkyCell in April 2020 that included a then undisclosed Mobiliar as well as family office investors, financial services firm…
